Goldman Sachs
CLMT icon

Goldman Sachs’s Calumet Specialty Products CLMT Stock Holding History

Goldman Sachs’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$90.1M Buy
+2,508,400
New +$64.9M 0.01% 1100
2021
Q3 		– Sell
-259,600
Closed -$1.78M – 6254
2021
Q2 		$1.78M Buy
+259,600
New +$1.6M ﹤0.01% 4310
2018
Q4 		– Sell
-1,000
Closed -$6K – 5276
2018
Q3 		$6K Buy
+1,000
New +$7.1K ﹤0.01% 5497
2018
Q2 		– Sell
-7,900
Closed -$56K – 5692
2018
Q1 		$56K Sell
7,900
-73,800
-90% -$545K ﹤0.01% 5446
2017
Q4 		$629K Sell
81,700
-6,500
-7% -$54.2K ﹤0.01% 4645
2017
Q3 		$736K Buy
88,200
+58,700
+199% +$366K ﹤0.01% 4823
2017
Q2 		$125K Sell
29,500
-8,100
-22% -$32.5K ﹤0.01% 6037
2017
Q1 		$143K Buy
37,600
+28,600
+318% +$113K ﹤0.01% 5895
2016
Q4 		$36K Sell
9,000
-3,100
-26% -$12.6K ﹤0.01% 6471
2016
Q3 		$55K Buy
12,100
+4,500
+59% +$23.2K ﹤0.01% 6439
2016
Q2 		$37K Sell
7,600
-14,000
-65% -$79.3K ﹤0.01% 6519
2016
Q1 		$254K Buy
21,600
+18,700
+645% +$260K ﹤0.01% 5404
2015
Q4 		$58K Sell
2,900
-1,400
-33% -$34.6K ﹤0.01% 6464
2015
Q3 		$104K Sell
4,300
-2,100
-33% -$54.6K ﹤0.01% 6457
2015
Q2 		$163K Sell
6,400
-1,500
-19% -$39.8K ﹤0.01% 6302
2015
Q1 		$190K Sell
7,900
-5,600
-41% -$142K ﹤0.01% 6054
2014
Q4 		$303K Buy
13,500
+7,400
+121% +$193K ﹤0.01% 5761
2014
Q3 		$167K Buy
6,100
+2,000
+49% +$60.4K ﹤0.01% 6300
2014
Q2 		$130K Sell
4,100
-4,400
-52% -$131K ﹤0.01% 6450
2014
Q1 		$220K Buy
8,500
+4,000
+89% +$109K ﹤0.01% 6001
2013
Q4 		$117K Sell
4,500
-9,600
-68% -$268K ﹤0.01% 6217
2013
Q3 		$385K Buy
14,100
+5,500
+64% +$173K ﹤0.01% 5361
2013
Q2 		$313K Buy
+8,600
New +$309K ﹤0.01% 5301

Other funds holding CLMT

TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WDOM
Wasserstein Debt Opportunities Management New York $189M AUM 169.75% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Goldman Sachs's CLMT Position: Q1 2026 in Review

Goldman Sachs increased its Calumet Specialty Products (CLMT) stake by 16% in Q1 2026, buying an estimated $1.4M and bringing the position to 402,089 shares worth $14.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2756.

Goldman Sachs first reported a position in CLMT in Q2 2013 and has held it in 52 quarters since. 180 funds tracked by Wall St. Rank hold CLMT as of Q1 2026.

  • Goldman Sachs held 402,089 shares of Calumet Specialty Products worth $14.4M as of Q1 2026.
  • Goldman Sachs bought 53,974 Calumet Specialty Products shares in Q1 2026, an estimated $1.4M.
  • Calumet Specialty Products made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #2756 holding.
  • Goldman Sachs first reported a position in Calumet Specialty Products in Q2 2013 and has held it in 52 quarters since.
  • 180 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.